Readers were questioned on their views on the status of commercialization of the biotechnology industry in general. When queried on whether they would foresee a multinational company emerging from Malaysia in the next ten years, readers were generally optimistic (64%) with a further 18% mentioned the possibility. This is contrasted by 12% who believed otherwise.

On their views on what would be an important factor in ensuring successful commercialization, readers were generally split, with 29% agreeing on policies and regulatory framework being most important, followed by a further 19% who believed collaboration was important, and 16% prioritizing research activities, 13% proper directions 10% entrepreneurial skills being developed among scientists, 6% on expertise, 3% funding and continuity.

When gauged on whether it was believed there were enough schemes and plans supporting scientists to commercialise their findings, readers were generally split. 54% expressed the possibility, followed by a further 11% responding positively, while 32% believed that there wasn’t enough schemes to support a good commercialization environment.

On the leading roles in commercialization, readers when queried generally believed that private companies should play such a role in commercialization (75%), this is augmented by 86% who believed the government should play such a role.